Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | ESR1 | P03372 | 2/20 | 0.44 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | KCNN4 | O15554 | 4/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.39 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.39 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.39 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.39 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.39 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL8601711 | 0.97 | MAPK1 (0.48) | MAPK1ALDH1A1TAAR1ALOX15ESR1 | |
| SCHEMBL4449679 | 0.81 | ESR1 (0.46) | MAPK1ALDH1A1TAAR1ALOX15ESR1 | |
| SCHEMBL842144 | 0.81 | MAPK1 (0.50) | MAPK1ALDH1A1TAAR1ALOX15ESR1 | |
| SCHEMBL2012032 | 0.77 | MAPK1 (0.46) | MAPK1ALDH1A1TAAR1ALOX15ESR1 | |
| SCHEMBL662183 | 0.77 | MAPK1 (0.46) | MAPK1ALDH1A1TAAR1ALOX15ESR1 | |
| SCHEMBL3264960 | 0.77 | MAPK1 (0.46) | MAPK1ALDH1A1TAAR1ALOX15ESR1 | |
| Hydrochloric Acid SCHEMBL8007212 | 0.77 | MAPK1 (0.46) | MAPK1ALDH1A1TAAR1ALOX15ESR1 | |
| SCHEMBL28902292 | 0.75 | MAPK1 (0.44) | MAPK1ALDH1A1TAAR1ALOX15ESR1 | |
| SCHEMBL16859261 | 0.75 | MAPK1 (0.44) | MAPK1ALDH1A1TAAR1ALOX15ESR1 | |
| SCHEMBL909383 | 0.75 | MAPK1 (0.44) | MAPK1ALDH1A1TAAR1ALOX15ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12435181-B2 | Formulations capable of reacting with or removal of molecular oxygen | LI SHENSHEN (US) | 2025-10-07 | — | — | US | disclosed |
| CN-119136667-A | Ready-to-use plant treatment agent applicators, containers, and products | UPL有限责任公司 | 2024-12-13 | — | — | CN | disclosed |
| WO-2023181905-A1 | LAMINATE MANUFACTURING METHOD | 日本発條株式会社 | 2023-09-28 | — | — | WO | disclosed |
| US-20230271953-A1 | Novel compounds for treatment of diseases related to DUX4 expression | Facio Intellectual Property B.V. (NL) | 2023-08-31 | — | — | US | disclosed |
| CN-112912364-B | Effect of catalyst concentration and solid activator on nickel-mediated coupling of olefins/carbon dioxide with acrylates | 切弗朗菲利浦化学公司 | 2023-07-07 | — | — | CN | disclosed |
| US-20220235174-A1 | Formulations capable of reacting with or removal of molecular oxygen | LI ZHENZHEN (CN) | 2022-07-28 | — | — | US | disclosed |
| CN-109071520-B | Microbicidal oxadiazole derivatives | 先正达参股股份有限公司 | 2022-06-14 | — | — | CN | disclosed |
| CN-114390888-A | Plant supplement delivery assembly, plant supplement delivery assembly insert and method for delivering plant supplement | 巴特尔纪念研究院 | 2022-04-22 | — | — | CN | disclosed |
| WO-2022033893-A1 | HERBICIDAL COMPOSITIONS | SYNGENTA CROP PROTECTION AG (CH) | 2022-02-17 | — | — | WO | disclosed |
| US-20210403702-A1 | THERMOSETTING EPOXY RESIN COMPOSITION, CIRCUT BOARD LAMINATE, METAL-BASED CIRCUT BOARD, AND POWER MODULE | NHK SPRING CO., LTD. (JP) | 2021-12-30 | — | — | US | disclosed |
| US-7256314-B2 | Method for generating secondary phosphines | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 2007-08-14 | — | — | US | disclosed |
| US-20070149820-A1 | METHOD FOR GENERATING SECONDARY PHOSPHINES | BUSACCA CARL A | 2007-06-28 | — | — | US | disclosed |
| EP-1732876-A1 | PREPARATION OF LEVULINIC ACID ESTERS FROM ALPHA-ANGELICA LACTONE AND ALCOHOLS | E.I.Du pont de nemours and company (US) | 2006-12-20 | — | — | EP | disclosed |
| WO-2005097724-A1 | PREPARATION OF LEVULINIC ACID ESTERS FROM ALPHA-ANGELICA LACTONE AND ALCOHOLS | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2005-10-20 | — | — | WO | disclosed |
| US-20050210738-A1 | Preparation of levulinic acid esters from alpha-angelica lactone and alcohols | E. I. DU PONT DE NEMOURS AND COMPANY | 2005-09-29 | — | — | US | disclosed |
| US-20050203314-A1 | Method for generating secondary phosphines | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 2005-09-15 | — | — | US | disclosed |
| WO-2005068479-A1 | A METHOD FOR GENERATING SECONDARY PHOSPHINES | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 2005-07-28 | — | — | WO | disclosed |
| EP-0536036-B1 | Cardioprotective tocopherol analogs | MERRELL PHARMA INC (US) | 1998-02-25 | — | — | EP | disclosed |
| EP-0536036-A1 | Cardioprotective tocopherol analogs | MERRELL PHARMACEUTICALS INC. (US) | 1993-04-07 | — | — | EP | disclosed |
| EP-0535283-A1 | Cardioprotective tocopherol analogs | MERRELL DOW PHARMACEUTICALS INC. (US) | 1993-04-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070149820-A1 | METHOD FOR GENERATING SECONDARY PHOSPHINES | HRH3, DBH, HDHD5 | MAPK1 4192/4885ALDH1A1 3016/4885TAAR1 543/4885 |
| US-20050210738-A1 | Preparation of levulinic acid esters from alpha-angelica lactone and alcohols | ADH1C, ADH1A, ADH5 | MAPK1 3617/4885ALDH1A1 6/4885TAAR1 2570/4885 |
| US-20230271953-A1 | Novel compounds for treatment of diseases related to DUX4 expression | UTRN, ZFX, CBX6 | MAPK1 4043/4885ALDH1A1 2505/4885TAAR1 4368/4885 |
| US-20050203314-A1 | Method for generating secondary phosphines | HRH3, DBH, HDHD5 | MAPK1 4192/4885ALDH1A1 3016/4885TAAR1 543/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.